Swedish Orphan Biovitrum Balance Sheet Health
Financial Health criteria checks 3/6
Swedish Orphan Biovitrum has a total shareholder equity of SEK37.1B and total debt of SEK17.5B, which brings its debt-to-equity ratio to 47.1%. Its total assets and total liabilities are SEK72.2B and SEK35.1B respectively. Swedish Orphan Biovitrum's EBIT is SEK6.1B making its interest coverage ratio 4.5. It has cash and short-term investments of SEK594.0M.
Key information
47.1%
Debt to equity ratio
SEK 17.47b
Debt
| Interest coverage ratio | 4.5x |
| Cash | SEK 594.00m |
| Equity | SEK 37.11b |
| Total liabilities | SEK 35.09b |
| Total assets | SEK 72.20b |
Recent financial health updates
Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Jun 24
Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Mar 05Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Nov 24Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jul 07Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Apr 02These 4 Measures Indicate That Swedish Orphan Biovitrum (STO:SOBI) Is Using Debt Reasonably Well
Dec 27Recent updates
Swedish Orphan Biovitrum AB (publ) Just Beat EPS By 95%: Here's What Analysts Think Will Happen Next
Oct 27Earnings Beat: Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 19Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Jun 24Here's Why Shareholders May Consider Paying Swedish Orphan Biovitrum AB (publ)'s (STO:SOBI) CEO A Little More
May 08Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 27Investors Still Waiting For A Pull Back In Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Apr 24Swedish Orphan Biovitrum AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 06Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Mar 05Swedish Orphan Biovitrum's (STO:SOBI) Weak Earnings May Only Reveal A Part Of The Whole Picture
Feb 15Swedish Orphan Biovitrum AB (publ)'s (STO:SOBI) Earnings Haven't Escaped The Attention Of Investors
Jan 17Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Nov 24Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jul 07Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Apr 02Is Swedish Orphan Biovitrum AB (publ) (STO:SOBI) Trading At A 30% Discount?
Jan 11These 4 Measures Indicate That Swedish Orphan Biovitrum (STO:SOBI) Is Using Debt Reasonably Well
Dec 27Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Sep 28Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jun 26Financial Position Analysis
Short Term Liabilities: SOBI's short term assets (SEK12.6B) do not cover its short term liabilities (SEK13.9B).
Long Term Liabilities: SOBI's short term assets (SEK12.6B) do not cover its long term liabilities (SEK21.2B).
Debt to Equity History and Analysis
Debt Level: SOBI's net debt to equity ratio (45.5%) is considered high.
Reducing Debt: SOBI's debt to equity ratio has reduced from 55.4% to 47.1% over the past 5 years.
Debt Coverage: SOBI's debt is well covered by operating cash flow (38.1%).
Interest Coverage: SOBI's interest payments on its debt are well covered by EBIT (4.5x coverage).